Spero Therapeutics, Inc. (SPRO) SEC Filings — 2025
13 SEC filings for Spero Therapeutics, Inc. (SPRO) in 2025.
Filings
- Spero Therapeutics Files 8-K — 8-K · Dec 19, 2025
- Spero Narrows Losses, Pivots to Tebipenem HBr Amid Program Cuts — 10-Q · Nov 13, 2025
- Spero Therapeutics Files 8-K on Financials — 8-K · Aug 12, 2025
- Spero's Q2 Loss Widens to $19.9M Amid R&D Shifts — 10-Q · Aug 12, 2025
- Spero Therapeutics Reports Director/Officer Changes & Shareholder Votes — 8-K · Jun 18, 2025
- Spero Therapeutics Files 8-K Report — 8-K · May 28, 2025
- Spero Therapeutics Files 8-K on Financials — 8-K · May 13, 2025
- Spero Therapeutics Files Q1 2025 10-Q — 10-Q · May 13, 2025
- Spero Therapeutics Files 8-K: Officer/Director Changes & Financials — 8-K · Apr 28, 2025
- Spero Therapeutics Files 8-K on Financials — 8-K · Mar 27, 2025
- Spero Therapeutics Files 2024 10-K — 10-K · Mar 27, 2025
- Spero Therapeutics to be Delisted from Nasdaq — 8-K · Feb 28, 2025
- Spero Therapeutics Files 8-K — 8-K · Jan 10, 2025